Population-Level Trends in Asthma Exacerbations After Introduction of Respiratory Biologics - Takeaways - MDSpire

Population-Level Trends in Asthma Exacerbations After Introduction of Respiratory Biologics

  • By

  • Yung-Fang Tu

  • David W. Stein

  • Ayobami Akenroye

  • June 24, 2026

  • 0 min

Share

  • 1

    Asthma significantly contributes to global morbidity and mortality, especially among patients with severe asthma.

  • 2

    The approval of monoclonal antibodies has provided alternatives to systemic corticosteroids for severe asthma management.

  • 3

    The respiratory biologics boom occurred between 2015 and 2018, with multiple biologics approved for asthma treatment.

  • 4

    This study analyzed population-level asthma exacerbation trends before and after the introduction of respiratory biologics.

  • 5

    Subgroup analyses were conducted to assess treatment effects based on demographic and clinical characteristics.

Original Source(s)

Population-Level Trends in Asthma Exacerbations After Introduction of Respiratory Biologics

  • by Yung-Fang Tu, David W. Stein, Ayobami Akenroye

  • June 24, 2026

Related Content

Changes in the Use of Montelukast for Asthma After a US Food and Drug Administration Boxed Warning

Impulse oscillometry values calibrated against spirometric obstruction in children with suspected asthma

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.